Published in Virol J on December 13, 2011
Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology. PLoS One (2014) 1.02
Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load. BMC Infect Dis (2012) 0.82
LTR point mutations in the Tax-responsive elements of HTLV-1 isolates from HIV/HTLV-1-coinfected patients. Virol J (2012) 0.78
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A (1983) 14.09
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science (1985) 6.60
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene (2005) 2.96
Chronic inflammatory arthropathy associated with HTLV-I. Lancet (1989) 2.28
T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet (1988) 1.89
HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J Biol Chem (1989) 1.87
The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol (1991) 1.85
T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet (1987) 1.77
Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene (2003) 1.66
Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene (2005) 1.64
Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins. EMBO J (1990) 1.63
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood (2010) 1.57
Indirect binding of human T-cell leukemia virus type I tax1 to a responsive element in the viral long terminal repeat. Mol Cell Biol (1989) 1.55
In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol (1991) 1.46
Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene (2005) 1.45
Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proc Natl Acad Sci U S A (1987) 1.41
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia (2003) 1.39
HTLV-I and uveitis. Lancet (1992) 1.38
Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J Biol Chem (2002) 1.34
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med (2000) 1.32
Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol (1992) 1.19
Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int J Cancer (1991) 1.10
Prevalence of human herpesvirus 8 DNA sequences in several patient populations. J Clin Microbiol (1996) 1.07
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci (2004) 1.05
Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire. AIDS Res Hum Retroviruses (1994) 0.98
Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America. J Gen Virol (1998) 0.98
Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J Gen Virol (1994) 0.92
The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ (2005) 0.91
Hashimoto's thyroiditis in HTLV-I carriers. Intern Med (1992) 0.85
Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res Hum Retroviruses (1994) 0.83
WHO comparative evaluation of serologic assays for Chagas disease. Transfusion (2009) 2.80
Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion (2005) 1.84
Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion (2009) 1.68
Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion (2008) 1.62
[The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil]. Rev Panam Salud Publica (2003) 1.55
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS (2003) 1.47
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS (2003) 1.45
Knowledge, attitudes and motivations among blood donors in São Paulo, Brazil. AIDS Behav (2008) 1.38
GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS (2009) 1.34
Profile of blood donors with serologic tests reactive for the presence of syphilis in São Paulo, Brazil. Transfusion (2009) 1.32
Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses (2006) 1.27
Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil. Transfusion (2011) 1.22
HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica (2006) 1.19
The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil. Transfusion (2009) 1.18
Trends in the profile of blood donors at a large blood center in the city of São Paulo, Brazil. Rev Panam Salud Publica (2003) 1.18
Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance. PLoS One (2012) 1.18
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. AIDS (2006) 1.14
Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis (2013) 1.11
Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol (2009) 1.07
Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. AIDS Res Hum Retroviruses (2012) 1.01
HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV. J Acquir Immune Defic Syndr (2013) 1.00
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr (2006) 1.00
Analysis of donor deferral at three blood centers in Brazil. Transfusion (2012) 0.96
Investigation Into an Outbreak of Dengue-like Illness in Pernambuco, Brazil, Revealed a Cocirculation of Zika, Chikungunya, and Dengue Virus Type 1. Medicine (Baltimore) (2016) 0.91
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy. Adv Hematol (2010) 0.89
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure. Infect Genet Evol (2008) 0.89
Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic. Virology (2008) 0.88
Methodological Guidelines for Reducing the Complexity of Data Warehouse Development for Transactional Blood Bank Systems. Decis Support Syst (2013) 0.88
Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil. Transfusion (2012) 0.88
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission. BMC Blood Disord (2010) 0.87
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS Negl Trop Dis (2011) 0.86
Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One (2011) 0.85
High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One (2009) 0.85
Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects. PLoS One (2013) 0.85
No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop Sao Paulo (2002) 0.85
The Brazilian network for HIV-1 genotyping external quality control assurance programme. J Int AIDS Soc (2011) 0.84
[External serology quality control programs developed in Latin America with the support of PAHO from 1997 through 2000]. Rev Panam Salud Publica (2003) 0.84
Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: a multi-center serosurvey. J Med Virol (2008) 0.83
Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions. Rev Bras Hematol Hemoter (2012) 0.83
Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication. PLoS One (2010) 0.82
Evaluation of primary resistance to HIV entry inhibitors among brazilian patients failing reverse transcriptase/protease inhibitors treatment reveal high prevalence of maraviroc resistance-related mutations. AIDS Res Hum Retroviruses (2010) 0.82
Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load. BMC Infect Dis (2012) 0.82
Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis (2013) 0.82
Human herpesvirus type 8 among Brazilian blood donors. Transfusion (2003) 0.82
Predictors of low haematocrit among repeat donors in São Paulo, Brazil: eleven year longitudinal analysis. Transfus Apher Sci (2013) 0.81
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. PLoS One (2013) 0.81
Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B. AIDS Res Hum Retroviruses (2013) 0.78
Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. Virology (2006) 0.78
New prevalence estimate of TT virus (TTV) infection in low- and high-risk population from São Paulo, Brazil. Rev Inst Med Trop Sao Paulo (2002) 0.78
DBCollHIV: a database system for collaborative HIV analysis in Brazil. Genet Mol Res (2006) 0.77
Genotype distribution of the GB virus C in citizens of São Paulo City, Brazil. Rev Inst Med Trop Sao Paulo (2003) 0.77
Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy. Clin Med Insights Oncol (2010) 0.76
Re: "WHO evaluation of the serologic assays for Chagas disease". Transfusion (2010) 0.75
Blood Donor Test-Seeking Motivation and Prior HIV Testing Experiences in São Paulo, Brazil. AIDS Behav (2015) 0.75
The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation. J Transplant (2009) 0.75
Evaluation of the concomitant use of two different EIA tests for HIV screening in blood banks. Rev Panam Salud Publica (2003) 0.75
Spread of Chikungunya Virus East/Central/South African Genotype in Northeast Brazil. Emerg Infect Dis (2017) 0.75
Dasatinib overrides imatinib resistance mediated by the F359I residue mutation in two patients with chronic myeloid leukemia. Acta Haematol (2011) 0.75
Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021. Emerg Infect Dis (2021) 0.75